<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheng FW</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>372-378</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10949089</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(4)</volume><pubmed_abstract>Dietary fiber and phytonutrients can protect against colorectal cancer, yet their consumption is low in the US. Avocados are a potential source of these beneficial nutrients. Therefore, this study aimed to examine the relationship between avocados/guacamole consumption and colorectal cancer risk in the Multiethnic Cohort Study. We assessed avocados/guacamole consumption by using a food frequency questionnaire. We classified participants into three consumer groups: &lt;1 serving/month, 1-3 servings/month, and ≥1 serving/week with one serving defined as ½ avocado or ½ cup. Colorectal cancer cases were ascertained through the Surveillance, Epidemiology and End Results Program cancer registries. Cox proportional hazards models of colorectal cancer were used to calculate hazard ratios and 95% confidence intervals across avocados/guacamole intake groups in each sex overall and by anatomic subsite (i.e., right colon, left colon, and rectum) and race and ethnicity. Of 192,651 eligible participants, 62.8% reported consuming &lt;1 serving/month avocados/guacamole, 26.7% reported 1-3 servings/month, and 10.5% reported ≥1 serving/week. When adjusted for relevant covariates, there was no significant association with incident colorectal cancer overall, for subsites, or within racial and ethnic subgroups (all p for trend ≥ 0.06). In this large prospective cohort study, we did not find that consumption of avocados/guacamole was associated with colorectal cancer risk.</pubmed_abstract><journal>Nutrition and cancer</journal><pubmed_title>Avocado and Guacamole Consumption and Colorectal Cancer Risk: The Multiethnic Cohort Study.</pubmed_title><pmcid>PMC10949089</pmcid><funding_grant_id>U01 CA164973</funding_grant_id><funding_grant_id>P30 CA071789</funding_grant_id><pubmed_authors>Wilkens LR</pubmed_authors><pubmed_authors>Cheng FW</pubmed_authors><pubmed_authors>Ford NA</pubmed_authors><pubmed_authors>Park SY</pubmed_authors><pubmed_authors>Haiman CA</pubmed_authors><pubmed_authors>Le Marchand L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Avocado and Guacamole Consumption and Colorectal Cancer Risk: The Multiethnic Cohort Study.</name><description>Dietary fiber and phytonutrients can protect against colorectal cancer, yet their consumption is low in the US. Avocados are a potential source of these beneficial nutrients. Therefore, this study aimed to examine the relationship between avocados/guacamole consumption and colorectal cancer risk in the Multiethnic Cohort Study. We assessed avocados/guacamole consumption by using a food frequency questionnaire. We classified participants into three consumer groups: &lt;1 serving/month, 1-3 servings/month, and ≥1 serving/week with one serving defined as ½ avocado or ½ cup. Colorectal cancer cases were ascertained through the Surveillance, Epidemiology and End Results Program cancer registries. Cox proportional hazards models of colorectal cancer were used to calculate hazard ratios and 95% confidence intervals across avocados/guacamole intake groups in each sex overall and by anatomic subsite (i.e., right colon, left colon, and rectum) and race and ethnicity. Of 192,651 eligible participants, 62.8% reported consuming &lt;1 serving/month avocados/guacamole, 26.7% reported 1-3 servings/month, and 10.5% reported ≥1 serving/week. When adjusted for relevant covariates, there was no significant association with incident colorectal cancer overall, for subsites, or within racial and ethnic subgroups (all p for trend ≥ 0.06). In this large prospective cohort study, we did not find that consumption of avocados/guacamole was associated with colorectal cancer risk.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-04T09:08:44.954Z</modification><creation>2025-04-04T09:08:44.954Z</creation></dates><accession>S-EPMC10949089</accession><cross_references><pubmed>38425005</pubmed><doi>10.1080/01635581.2024.2320950</doi></cross_references></HashMap>